Viewing Study NCT00828503

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:22 PM
Ignite Modification Date: 2026-01-01 @ 11:59 PM
Study NCT ID: NCT00828503
Status: UNKNOWN
Last Update Posted: 2012-09-03
First Post: 2009-01-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients
Sponsor: Marcus Saemann
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cytomegalovirus Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Certi-CMV View
None immunosuppressive switch (to Certican) View
None renal transplant View